Brief: Xeris Biopharma Q1 Net Income USD -18.98 Million
May 09 (Reuters) - Xeris Biopharma Q1 product revenue USD 40.263 million vs. IBES estimate USD 41.8 million. * Q1 operating income USD -14.245 million * Q1 basic EPS USD -0.14
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest